In conclusion, MLD and other lysosomal disorders are considered to be orphan diseases but the expected incidence of fetuses conceived with two pathogenic ARSA mutations of 4.1 in 100 000 and heterozygote frequency of 1 in 79 negate this statement. The gene discussed is ARSA; the disease is metachromatic leukodystrophy.